Point72 Hong Kong’s Ventyx Biosciences VTYX Stock Holding History

Point72 Hong Kong’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,175	Closed	-$16K	–	2454
2022 Q1	$16K	Buy	+1,175	New	+$15.7K	﹤0.01%	1557

Other funds holding VTYX

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Hong Kong's VTYX Position: Q2 2022 in Review

Point72 Hong Kong sold out of Ventyx Biosciences (VTYX) in Q2 2022, closing a stake of 1,175 shares — an estimated $16K sold.

Point72 Hong Kong first reported a position in VTYX in Q1 2022 and held it in 1 quarter. The position peaked at $16K in Q1 2022. 63 funds tracked by Wall St. Rank hold VTYX as of Q2 2022.

Point72 Hong Kong reported no remaining Ventyx Biosciences position as of Q2 2022 after selling out during the quarter.
Point72 Hong Kong sold 1,175 Ventyx Biosciences shares in Q2 2022, an estimated $16K.
Point72 Hong Kong first reported a position in Ventyx Biosciences in Q1 2022 and held it in 1 quarter.
Point72 Hong Kong's Ventyx Biosciences position peaked at $16K in Q1 2022.
63 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.